Feng Lin
Chief Tech/Sci/R&D Officer presso THERAPEUTIC SOLUTIONS INTERNATIONAL, INC.
Patrimonio netto: 50 000 $ in data 31/03/2024
Profilo
Feng Lin is currently the Chief Scientific Officer at Therapeutic Solutions International, Inc. He previously worked as the Director of Chinese Operations at Medistem, Inc. from 2012 to 2014, Senior Scientist at Inovio Pharmaceuticals, Inc. from 2007 to 2012, and Associate at Sanford Burnham Prebys Medical Discovery Institute from 1999 to 2005.
He was also the Chief Scientific Officer at SuperView Biotechnology Co. Ltd.
from 2014 to 2019.
Dr. Lin has a doctorate degree from Central South University, which he received in 1998, as well as a graduate degree and an undergraduate degree from the same university, which he received in 1994 and 1990, respectively.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
31/12/2022 | 50 000 000 ( 1.30% ) | 50 000 $ | 31/03/2024 |
Posizioni attive di Feng Lin
Società | Posizione | Inizio |
---|---|---|
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Chief Tech/Sci/R&D Officer | 03/09/2019 |
Precedenti posizioni note di Feng Lin
Società | Posizione | Fine |
---|---|---|
SuperView Biotechnology Co. Ltd. | Chief Tech/Sci/R&D Officer | 01/08/2019 |
MEDISTEM INC | Corporate Officer/Principal | 01/05/2014 |
INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2012 |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Corporate Officer/Principal | 01/12/2005 |
RIVULET MEDIA, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Feng Lin
Central South University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
INOVIO PHARMACEUTICALS, INC. | Health Technology |
RIVULET MEDIA, INC. | Technology Services |
ENTEST GROUP, INC. | Finance |
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. | Health Technology |
Aziende private | 3 |
---|---|
Medistem, Inc.
Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
SuperView Biotechnology Co. Ltd. |
- Borsa valori
- Insiders
- Feng Lin